Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$95.27 - $108.47 $2.92 Million - $3.33 Million
30,681 New
30,681 $2.97 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $1.56 Million - $1.74 Million
-16,506 Reduced 52.74%
14,793 $1.51 Million
Q2 2023

Aug 11, 2023

BUY
$92.52 - $104.91 $116,482 - $132,081
1,259 Added 4.19%
31,299 $3.16 Million
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $1.09 Million - $1.26 Million
13,564 Added 82.33%
30,040 $2.76 Million
Q4 2022

Feb 08, 2023

SELL
$75.55 - $92.52 $2.73 Million - $3.35 Million
-36,155 Reduced 68.7%
16,476 $1.49 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $2.08 Million - $2.43 Million
27,818 Added 112.11%
52,631 $4 Million
Q2 2022

Aug 11, 2022

BUY
$80.52 - $93.75 $2 Million - $2.33 Million
24,813 New
24,813 $2.1 Million
Q1 2022

May 12, 2022

SELL
$80.11 - $90.62 $1.03 Million - $1.16 Million
-12,831 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $1.93 Million - $2.14 Million
-24,248 Reduced 65.4%
12,831 $1.12 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $1.42 Million - $1.65 Million
17,326 Added 87.71%
37,079 $3.03 Million
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $1.35 Million - $1.5 Million
15,888 Added 411.07%
19,753 $1.8 Billion
Q1 2021

May 17, 2021

BUY
$83.5 - $98.47 $322,727 - $380,586
3,865 New
3,865 $330 Million
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $135,373 - $163,741
-1,734 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $46,655 - $51,688
568 Added 48.71%
1,734 $151 Million
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $255,738 - $287,876
-3,160 Reduced 73.05%
1,166 $102 Million
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $1.61 Million - $2.26 Million
-22,832 Reduced 84.07%
4,326 $356,000
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $2.29 Million - $2.59 Million
27,158 New
27,158 $2.57 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.